Â
The UTEST 12 Panel Test Kit is a comprehensive multi-drug testing kit designed for easy, one-step self-testing. It provides accurate results within 5 minutes and offers customer service support along with clear instructions and test interpretations on the packaging. This kit is proudly made in the USA.
Detects the following substances:
A convenient and reliable choice for comprehensive drug testing needs.
Â
Â
UTest 12 Panel Test Kit is a multi-panel drug-screening kit designed to screen for 12 designated drug categories or analytes using a single testing system. Its comprehensive panel format provides broader preliminary screening coverage than standard 5-panel or 10-panel kits, making it a practical option for customers seeking multi-substance screening. The exact substances detected, cutoff concentrations, specimen type, and result-reading time should be confirmed through the manufacturer's instructions. For customers in the United States and Canada, UTest 12 Panel Test Kit provides preliminary screening information, with unexpected positive results requiring appropriate laboratory confirmation.
UTest 12 Panel Test Kit is a multi-panel drug-screening product designed to screen for 12 designated substance categories or analytes.
A 12-panel drug test screens for 12 specified drug categories or analytes. Common configurations may include THC, cocaine, amphetamines, opiates, benzodiazepines, and other substances, but the exact UTest panel list requires manufacturer confirmation.
A 12-panel test screens for 12 designated categories or analytes, compared with five in a 5-panel test. The exact substances included vary by manufacturer.
Many multi-panel drug-screening kits use urine specimens. The required specimen type for this exact model should be verified from the manufacturer's instructions.
THC is commonly included in multi-panel drug tests, but its inclusion in this specific kit should be confirmed from the manufacturer's panel list.
Cocaine-related metabolites are frequently included in multi-panel screening configurations. Check the official product documentation for confirmation.
Not necessarily. Fentanyl requires a specifically designated assay and should not be assumed to be included simply because the kit has 12 panels.
Benzodiazepines are included in some 12-panel configurations. Verify the exact analytes listed on the packaging.
Some configurations include opiate or opioid screening panels. However, an opiate panel does not necessarily detect every opioid medication or synthetic opioid.
Methamphetamine is included in many expanded drug-screening panels, but its inclusion in this model requires confirmation.
Each panel may have a different cutoff concentration. The exact cutoff values should be verified from the manufacturer's specifications.
Accuracy depends on the manufacturer's validated performance, proper specimen collection, storage conditions, and correct result interpretation.
The exact result-reading time has not been independently verified. Follow the manufacturer's specified reading window.
Yes. Preliminary drug-screening tests can produce false-positive results. Unexpected positives should be confirmed using an appropriate laboratory method.
Yes. False negatives may occur when an analyte is below the detection cutoff or when other testing limitations affect detection.
No. A preliminary positive result is not definitive proof of drug use without appropriate confirmatory testing.
No. A negative result generally indicates that the tested analytes were not detected at or above their specified cutoffs. Substances outside the panel are not assessed.
Certain medications or related compounds may affect some screening assays. Unexpected results should be reviewed with a qualified healthcare professional or laboratory.
Rapid drug-screening kits are generally single-use devices. Confirm the manufacturer's instructions for this specific model.
Availability depends on retailer inventory, product classification, import eligibility, and applicable regulations.
A 12-panel drug test provides preliminary screening for multiple designated drug categories or analytes within a single testing process.
A 12-panel test screens for two additional designated categories or analytes compared with a 10-panel test, although the exact substances may differ between products.
It may be suitable for home screening if the manufacturer designates it for that purpose. Always follow the product instructions.
Suitability depends on the employer's testing program and applicable regulations. A consumer screening kit should not automatically be considered equivalent to a certified workplace laboratory test.
Workplace testing requirements vary by industry, province, and circumstances. Employers should follow applicable Canadian legal, privacy, and testing standards.
No. A preliminary screening result cannot reliably establish the exact time of substance use.
No. Detection of a substance or its metabolites does not necessarily establish current impairment.
Most rapid multi-panel tests provide qualitative results based on cutoff concentrations rather than precise quantitative measurements.
No. It only screens for the substances or analytes specifically included in its configuration.
An invalid result indicates that the test did not meet its required validity criteria. Follow the manufacturer's instructions for resolving or repeating the test.
FDA clearance has not been independently verified for this exact product. Check official regulatory records and manufacturer documentation.
Health Canada authorization has not been independently verified for this model.
Seek confirmation through an appropriate accredited laboratory before making important medical, employment, or legal decisions.
| Feature | Information |
|---|---|
| Product Name | UTest 12 Panel Test Kit |
| Brand | UTest |
| Product Category | Multi-panel drug-screening test |
| Number of Panels | 12 |
| Test Type | Preliminary drug screening |
| Substances Detected | 12 designated categories or analytes; exact list requires confirmation |
| Specimen Type | Manufacturer confirmation required |
| Cutoff Concentrations | Manufacturer confirmation required |
| Test Format | Manufacturer confirmation required |
| Result Time | Manufacturer confirmation required |
| Package Contents | Manufacturer confirmation required |
| Reusability | Follow manufacturer instructions |
| Regulatory Status | Not independently verified |
| Markets Addressed | United States and Canada |
Read the manufacturer's complete instructions before collecting a specimen or interpreting results. Verify the substances included in the 12-panel configuration, their cutoff concentrations, expiration date, and specimen requirements.
UTest 12 Panel Test Kit provides preliminary screening information rather than definitive laboratory confirmation. Unexpected positive results should be confirmed through an appropriate accredited laboratory.
A negative result does not guarantee the absence of all drugs, particularly substances not included in the panel or present below the applicable cutoff.
Testing requirements and regulatory standards may differ between the United States and Canada.
UTest 12 Panel Test Kit provides broad preliminary drug-screening coverage by combining 12 designated screening panels into one testing system. Compared with smaller multi-panel kits, it offers additional screening categories while maintaining the convenience of a single product.
For customers in the USA and Canada, the kit's usefulness depends on verifying the exact substances detected, following the manufacturer's instructions, and obtaining laboratory confirmation when necessary.
